Global and United States Biosimilars/follow-on-biologics Market Size, Status and Forecast 2020-2026

    • ID: AR2972459
    • 06 October, 2020
    • Other
    • Region: Global
    • 91 Pages
    • QYResearch

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type: 2020 VS 2026
      • 1.2.2 Human growth hormone
      • 1.2.3 Erythropoietin
      • 1.2.4 Monoclonal antibodies
      • 1.2.5 Insulin
      • 1.2.6 Interferon
      • 1.2.7 Granulocyte-Colony Stimulating Factor
      • 1.2.8 Others
    • 1.3 Market by Application
      • 1.3.1 Global Biosimilars/follow-on-biologics Market Share by Application: 2020 VS 2026
      • 1.3.2 Blood disorders
      • 1.3.3 Oncology diseases
      • 1.3.4 Chronic and autoimmune diseases
      • 1.3.5 Growth hormone deficiencies
      • 1.3.6 Others
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Global Growth Trends

    • 2.1 Global Biosimilars/follow-on-biologics Market Perspective (2015-2026)
    • 2.2 Global Biosimilars/follow-on-biologics Growth Trends by Regions
      • 2.2.1 Biosimilars/follow-on-biologics Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Biosimilars/follow-on-biologics Historic Market Share by Regions (2015-2020)
      • 2.2.3 Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Market Restraints

    3 Competition Landscape by Key Players

    • 3.1 Global Top Biosimilars/follow-on-biologics Players by Market Size
      • 3.1.1 Global Top Biosimilars/follow-on-biologics Players by Revenue (2015-2020)
      • 3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2015-2020)
    • 3.2 Global Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.3 Players Covered: Ranking by Biosimilars/follow-on-biologics Revenue
    • 3.4 Global Biosimilars/follow-on-biologics Market Concentration Ratio
      • 3.4.1 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Biosimilars/follow-on-biologics Revenue in 2019
    • 3.5 Key Players Biosimilars/follow-on-biologics Area Served
    • 3.6 Key Players Biosimilars/follow-on-biologics Product Solution and Service
    • 3.7 Date of Enter into Biosimilars/follow-on-biologics Market
    • 3.8 Mergers & Acquisitions, Expansion Plans

    4 Biosimilars/follow-on-biologics Breakdown Data by Type (2015-2026)

    • 4.1 Global Biosimilars/follow-on-biologics Historic Market Size by Type (2015-2020)
    • 4.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2021-2026)

    5 Biosimilars/follow-on-biologics Breakdown Data by Application (2015-2026)

    • 5.1 Global Biosimilars/follow-on-biologics Historic Market Size by Application (2015-2020)
    • 5.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Biosimilars/follow-on-biologics Market Size (2015-2026)
    • 6.2 North America Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
    • 6.3 North America Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
    • 6.4 North America Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
      • 6.4.1 United States
      • 6.4.2 Canada

    7 Europe

    • 7.1 Europe Biosimilars/follow-on-biologics Market Size (2015-2026)
    • 7.2 Europe Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
    • 7.3 Europe Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
    • 7.4 Europe Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
      • 7.4.1 Germany
      • 7.4.2 France
      • 7.4.3 U.K.
      • 7.4.4 Italy
      • 7.4.5 Russia
      • 7.4.6 Nordic
      • 7.4.7 Rest of Europe

    8 China

    • 8.1 China Biosimilars/follow-on-biologics Market Size (2015-2026)
    • 8.2 China Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
    • 8.3 China Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
    • 8.4 China Biosimilars/follow-on-biologics Market Size by Region (2015-2020)
      • 8.4.1 China
      • 8.4.2 Japan
      • 8.4.3 South Korea
      • 8.4.4 Southeast Asia
      • 8.4.5 India
      • 8.4.6 Australia
      • 8.4.7 Rest of Asia-Pacific

    9 Japan

    • 9.1 Japan Biosimilars/follow-on-biologics Market Size (2015-2026)
    • 9.2 Japan Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
    • 9.3 Japan Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
    • 9.4 Japan Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
      • 9.4.1 Mexico
      • 9.4.2 Brazil

    10 Southeast Asia

    • 10.1 Southeast Asia Biosimilars/follow-on-biologics Market Size (2015-2026)
    • 10.2 Southeast Asia Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
    • 10.3 Southeast Asia Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
    • 10.4 Southeast Asia Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
      • 10.4.1 Turkey
      • 10.4.2 Saudi Arabia
      • 10.4.3 UAE
      • 10.4.4 Rest of Middle East & Africa

    11 Key Players Profiles

    • 11.1 Novartis (Sandoz)
      • 11.1.1 Novartis (Sandoz) Company Details
      • 11.1.2 Novartis (Sandoz) Business Overview
      • 11.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Introduction
      • 11.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2015-2020))
      • 11.1.5 Novartis (Sandoz) Recent Development
    • 11.2 Synthon Pharmaceuticals
      • 11.2.1 Synthon Pharmaceuticals Company Details
      • 11.2.2 Synthon Pharmaceuticals Business Overview
      • 11.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Introduction
      • 11.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
      • 11.2.5 Synthon Pharmaceuticals Recent Development
    • 11.3 Teva Pharmaceutical Industries
      • 11.3.1 Teva Pharmaceutical Industries Company Details
      • 11.3.2 Teva Pharmaceutical Industries Business Overview
      • 11.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Introduction
      • 11.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
      • 11.3.5 Teva Pharmaceutical Industries Recent Development
    • 11.4 LG Life Sciences
      • 11.4.1 LG Life Sciences Company Details
      • 11.4.2 LG Life Sciences Business Overview
      • 11.4.3 LG Life Sciences Biosimilars/follow-on-biologics Introduction
      • 11.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
      • 11.4.5 LG Life Sciences Recent Development
    • 11.5 Celltrion Biocon
      • 11.5.1 Celltrion Biocon Company Details
      • 11.5.2 Celltrion Biocon Business Overview
      • 11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Introduction
      • 11.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
      • 11.5.5 Celltrion Biocon Recent Development
    • 11.6 Hospira
      • 11.6.1 Hospira Company Details
      • 11.6.2 Hospira Business Overview
      • 11.6.3 Hospira Biosimilars/follow-on-biologics Introduction
      • 11.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
      • 11.6.5 Hospira Recent Development
    • 11.7 Merck Serono (Merck)
      • 11.7.1 Merck Serono (Merck) Company Details
      • 11.7.2 Merck Serono (Merck) Business Overview
      • 11.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Introduction
      • 11.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
      • 11.7.5 Merck Serono (Merck) Recent Development
    • 11.8 Biogen idec
      • 11.8.1 Biogen idec Company Details
      • 11.8.2 Biogen idec Business Overview
      • 11.8.3 Biogen idec Biosimilars/follow-on-biologics Introduction
      • 11.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
      • 11.8.5 Biogen idec Recent Development
    • 11.9 Genentech (Roche)
      • 11.9.1 Genentech (Roche) Company Details
      • 11.9.2 Genentech (Roche) Business Overview
      • 11.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Introduction
      • 11.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
      • 11.9.5 Genentech (Roche) Recent Development

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Disclaimer

      Global Biosimilars/follow-on-biologics Scope and Market Size
      Biosimilars/follow-on-biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars/follow-on-biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      Market segment by Type, the product can be split into
      Human growth hormone
      Erythropoietin
      Monoclonal antibodies
      Insulin
      Interferon
      Granulocyte-Colony Stimulating Factor
      Others

      Market segment by Application, split into
      Blood disorders
      Oncology diseases
      Chronic and autoimmune diseases
      Growth hormone deficiencies
      Others

      Based on regional and country-level analysis, the Biosimilars/follow-on-biologics market has been segmented as follows:
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Nordic
      Rest of Europe
      Asia-Pacific
      China
      Japan
      South Korea
      Southeast Asia
      India
      Australia
      Rest of Asia-Pacific
      Latin America
      Mexico
      Brazil
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Rest of Middle East & Africa

      In the competitive analysis section of the report, leading as well as prominent players of the global Biosimilars/follow-on-biologics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
      The key players covered in this study
      Novartis (Sandoz)
      Synthon Pharmaceuticals
      Teva Pharmaceutical Industries
      LG Life Sciences
      Celltrion Biocon
      Hospira
      Merck Serono (Merck)
      Biogen idec
      Genentech (Roche)



      Summary:
      Biosimilars/follow-on-biologics Market Research Report is about Biosimilars/follow-on-biologics Industry study. Get complete Biosimilars/follow-on-biologics market research report published after Market Study, Industrial Analysis with Trends & Statistics. Biosimilars/follow-on-biologics Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED